Barclays’s Tempest Therapeutics TPST Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $246 | Buy |
+222
| New | +$366 | ﹤0.01% | 5085 |
|
|
2021
Q2 | – | Sell |
-219
| Closed | -$51K | – | 5080 |
|
|
2021
Q1 | $51K | Sell |
219
-2,162
| -91% | -$874K | ﹤0.01% | 4195 |
|
|
2020
Q4 | $994K | Buy |
2,381
+1,858
| +355% | +$642K | ﹤0.01% | 2769 |
|
|
2020
Q3 | $166K | Buy |
523
+51
| +11% | +$17.3K | ﹤0.01% | 3964 |
|
|
2020
Q2 | $162K | Buy |
472
+149
| +46% | +$59.4K | ﹤0.01% | 4218 |
|
|
2020
Q1 | $333K | Buy |
323
+275
| +573% | +$401K | ﹤0.01% | 3908 |
|
|
2019
Q4 | $63K | Buy |
48
+24
| +100% | +$33.8K | ﹤0.01% | 5672 |
|
|
2019
Q3 | $33K | Sell |
24
-7
| -23% | -$11.3K | ﹤0.01% | 6084 |
|
|
2019
Q2 | $70K | Buy |
31
+23
| +288% | +$67.7K | ﹤0.01% | 5926 |
|
|
2019
Q1 | $22K | Buy |
+8
| New | +$17.7K | ﹤0.01% | 6326 |
|
|
2018
Q4 | – | Hold |
0
| – | – | – | 7329 |
|
|
2018
Q3 | – | Hold |
0
| – | – | – | 7392 |
|
|
2018
Q2 | – | Hold |
0
| – | – | – | 7285 |
|
|
2018
Q1 | – | Hold |
0
| – | – | – | 7333 |
|
|
2017
Q4 | – | Hold |
0
| – | – | – | 7113 |
|
|
2017
Q3 | – | Hold |
0
| – | – | – | 7048 |
|
|
2017
Q2 | – | Hold |
0
| – | – | – | 6932 |
|
|
2017
Q1 | – | Sell |
-4
| Closed | -$18.6K | – | 6632 |
|
|
2016
Q4 | $19K | Buy |
+4
| New | +$49.8K | ﹤0.01% | 5653 |
|
|
2016
Q3 | – | Hold |
0
| – | – | – | 6084 |
|
|
2016
Q2 | – | Hold |
0
| – | – | – | 5989 |
|
|
2016
Q1 | – | Sell |
-1
| Closed | -$21.1K | – | 5890 |
|
|
2015
Q4 | $30K | Sell |
1
-15
| -94% | -$495K | ﹤0.01% | 5048 |
|
|
2015
Q3 | $381K | Buy |
+16
| New | +$1.08M | ﹤0.01% | 3591 |
|
|
2015
Q2 | – | Hold |
0
| – | – | – | 5949 |
|
|
2015
Q1 | – | Sell |
-1
| Closed | -$133K | – | 5738 |
|
|
2014
Q4 | $82K | Buy |
+1
| New | +$73.2K | ﹤0.01% | 5358 |
|
|
2014
Q3 | – | Hold |
0
| – | – | – | 6952 |
|
|
2014
Q2 | – | Hold |
0
| – | – | – | 7415 |
|
|
2014
Q1 | – | Hold |
0
| – | – | – | 7340 |
|
|
2013
Q4 | – | Hold |
0
| – | – | – | 7373 |
|
|
2013
Q3 | – | Hold |
0
| – | – | – | 6939 |
|
|
2013
Q2 | – | Hold |
0
| – | – | – | 7311 |
|
Other funds holding TPST
SM
VVM
Barclays's TPST Position: Q2 2026 in Review
Barclays opened a new position in Tempest Therapeutics (TPST) in Q2 2026: 222 shares worth $246. The stake represents ﹤0.01% of the portfolio and ranks #5085 among its holdings. This is a return to the name: Barclays previously reported a position in TPST as recently as Q1 2021.
Barclays first reported a position in TPST in Q4 2014 and has held it in 14 quarters since. The position peaked at $994K in Q4 2020. 21 funds tracked by Wall St. Rank hold TPST as of Q2 2026.
- Barclays held 222 shares of Tempest Therapeutics worth $246 as of Q2 2026.
- Tempest Therapeutics was a new Barclays position in Q2 2026.
- Tempest Therapeutics made up ﹤0.01% of Barclays's portfolio in Q2 2026, its #5085 holding.
- Barclays first reported a position in Tempest Therapeutics in Q4 2014 and has held it in 14 quarters since.
- Barclays's Tempest Therapeutics position peaked at $994K in Q4 2020.
- 21 funds tracked by Wall St. Rank held Tempest Therapeutics as of Q2 2026.
Based on Barclays's 13F filing for Q2 2026, filed 14 Aug 2026.